Cargando…
Hormonal Agents for the Treatment of Depression Associated with the Menopause
Perimenopause marks the transition from a woman’s reproductive stage to menopause. Usually occurring between 42 and 52 years of age, it is determined clinically by the onset of irregular menstrual cycles or variable cycle lengths. Women are at an increased risk of depression and anxiety during perim...
Autores principales: | Herson, Megan, Kulkarni, Jayashri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355926/ https://www.ncbi.nlm.nih.gov/pubmed/35908135 http://dx.doi.org/10.1007/s40266-022-00962-x |
Ejemplares similares
-
The Role of Oestrogen and Other Hormones in the Pathophysiology and Treatment of Schizophrenia
por: Hayes, Emily, et al.
Publicado: (2012) -
Hormonal contraception and mood disorders
por: Mu, Eveline, et al.
Publicado: (2022) -
A Review of Hormone and Non-Hormonal Therapy Options for the Treatment of Menopause
por: Madsen, Tracy E, et al.
Publicado: (2023) -
New Possibilities for Hormonal Vaginal Treatment in Menopausal Women
por: Tomczyk, Katarzyna, et al.
Publicado: (2023) -
Depression in the menopause transition: risks in the changing hormone milieu as observed in the general population
por: Freeman, Ellen W.
Publicado: (2015)